Mode
Text Size
Log in / Sign up

Macrophage lipophagy serves as a promising therapeutic target for managing atherosclerosis and lipid homeostasisTraditional Chinese Medicine may target a key process in heart disease

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that macrophage lipophagy is a promising target for atherosclerosis, though clinical translation is not yet established.

This systematic review examines the role of macrophage lipophagy in maintaining lipid homeostasis and its potential as a therapeutic target for atherosclerosis. The review synthesizes evidence regarding the mechanisms by which Traditional Chinese Medicine (TCM) may exert anti-atherosclerosis effects through the regulation of macrophage lipophagy.

The authors conclude that macrophage lipophagy is a central component in lipid homeostasis. They identify TCM, including active metabolites, medicinal plants, and herbal formulas, as a potential avenue for developing comprehensive strategies for the prevention and management of atherosclerosis.

However, the authors note that while preclinical evidence regarding these mechanisms is robust, clinical translation faces significant challenges. The evidence for the specific therapeutic impact of TCM on atherosclerosis via lipophagy is currently not established in a clinical setting.

Clinicians may consider these findings as a basis for future research into novel pharmacological strategies. However, the current evidence is primarily focused on the biological mechanisms and lacks established clinical trial data for human patients.

How this fits prior evidence

This systematic review addresses a gap in the understanding of macrophage lipophagy as a target for atherosclerosis. It builds upon prior coverage of m64 modification and METTL3 regulators influencing lipid metabolism and the progression of atherosclerosis. It also relates to previous findings where Traditional Chinese Medicine was shown to have heterogeneous effects on microbial abundance and to modulate mitochondrial quality control for myocardial fibrosis.

Heart disease often starts with atherosclerosis, a condition where plaque builds up in the arteries. Scientists are looking for better ways to manage this. They have identified a specific process called macrophage lipophagy. This is a way that certain cells in the body break down and clear out fats to keep things balanced.

Research shows that this fat-clearing process is a key target for treating atherosclerosis. The study also found evidence that Traditional Chinese Medicine, which includes various herbal formulas and medicinal plants, may help regulate this specific process. This suggests that these traditional treatments could offer new ways to manage heart health.

While the evidence from lab studies is strong, it is important to note that moving these findings into human clinical treatments is still a challenge. Because the transition from lab research to everyday medical practice is not yet established, these results are currently early and need more study.

What this means for you:
Traditional Chinese Medicine may help manage heart disease by targeting a specific cell process that clears fat.

Common questions

What is macrophage lipophagy and why does it matter?

Macrophage lipophagy is a process where certain cells in your body break down and clear out fats. It plays a central role in maintaining lipid homeostasis, which means keeping fat levels balanced. Because of this, it is considered a promising target for treating atherosclerosis, a condition that affects the arteries.

How does Traditional Chinese Medicine relate to heart health?

The research found evidence that Traditional Chinese Medicine, including herbal formulas and medicinal plants, may have anti-atherosclerosis effects. These effects are linked to the regulation of macrophage lipophagy. This means these traditional treatments might offer new ways to manage and prevent heart disease.

Can I use Traditional Chinese Medicine to treat my heart condition now?

While the research shows promise, the transition from laboratory findings to actual clinical treatments for humans is not yet established. Because this research is still in the early stages of translation, you should speak with your doctor before making any changes to your heart health routine.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
Macrophage lipophagy, the selective autophagic degradation of intracellular lipid droplets, plays a central role in maintaining lipid homeostasis and has emerged as a promising therapeutic target for atherosclerosis (AS). This review systematically synthesizes the classification, molecular mechanisms, and key signaling networks of macrophage lipophagy. Moreover, recent evidence on the anti-AS effects of Traditional Chinese Medicine (TCM) mediated by the regulation of macrophage lipophagy has also been summarized and evaluated, including active metabolites, medicinal plants, herbal formulas and commercial Chinese polyherbal preparations. Despite robust preclinical evidence, challenges remain. Significant efforts are still required to facilitate clinical translation and offer novel comprehensive strategies for the prevention and management of AS.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.